Thales’ FlytEDGE Digitally Remasters the inflight Entertainment Experience
28.5.2024 13:00:00 EEST | Business Wire | Press release
Thales unveils FlytEDGE, a revolutionary connected cloud-based inflight entertainment system that will transform passenger engagement to the extraordinary. FlytEDGE is not like a traditional IFE system — with a sleek architecture, cutting-edge features, and unparalleled performance it enables airlines to stand out by bringing the ‘cool’ factor to each seat, offering fully-tailored passenger interactions:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240528532879/en/
(Photo: Thales)
- Live personalization for a journey filled with unique experiences
- Instantly stream favorites and never miss a beat, continue watching on all flights
- Immense volume of content to immerse passengers in a world of entertainment choices
Creating personalized experiences
Personalization is at the heart of FlytEDGE. Every passenger is one-of-a-kind and the system empowers airlines to recommend experiences tailored to each person's preferences. FlytEDGE is a true engagement platform offering boundless opportunities for connected and custom journeys. FlytEDGE delivers ‘just-for-you’ experiences never seen before. The system intelligently recommends content across domains, with an individually tailored and immersive entertainment experience.
Delivering the future of entertainment to each passenger
FlytEDGE is the IFEC industry’s first solution to feature edge caching. Passengers can now instantly stream their favorite entertainment using their personal video subscriptions and continue watching their favorite shows from the ground to the air and across flights.
Leveraging a state-of-the-art connected cloud architecture, the system breaks through barriers providing airlines with unparalleled flexibility to rapidly bring in any web-based service.
- Top game providers for interactive options that will captivate from take-off to touch down
- Video streamers that go beyond the blockbuster to bring infinite bingeable choices to passengers
With FlytEDGE airlines can integrate partners at the speed of consumer technology to create exhilarating experiences at the forefront of inflight entertainment.
Thales’ FlytEDGE solution features the best consumer technologies on the market. The system boasts cinematic 4K QLED HDR seatback displays to immerse passengers with over 1 billon vibrant colors and two Bluetooth® connections so passengers can pair their personal wireless devices. The system broadcasts the same user interface onboard for all devices- phones, tablets and seatback screens. With Thales’ Crystal Cabin® award-winning power solution delivering high-speed charging at each seat to any passenger device, everyone arrives at their destination recharged, entertained, and relaxed.
Value for airline customers
FlytEDGE features the Crystal Cabin® award-winning Onboard Data Center (ODC) with 96TB of storage to enable on-board edge caching, this solution reduces connectivity consumption and ensures bandwidth is available for other inflight services. No matter how many people watch the same content, each title streams once to the aircraft allowing passengers to instantly access endless entertainment.
The ODC takes the IFE system performance to new heights.
- Replaces the traditional multi-server network with an effective and compact blade architecture
- Simplifies upgradeability path with easy blade swaps
- Ensures the highest system availability
FlytEDGE goes beyond the hardware by redefining software and content updates to reduce cost and lead-time.
- Exceptional Efficiency – Remote operations with virtual labs for anywhere, anytime updates
- Superior Performance – Real-time system monitoring and automated maintenance tasks
- Scalable and Evolving – Continuous integration of new services for a system that is always growing at the speed of consumer technologies
FlytEDGE is already flying! We’re just at the beginning of what’s possible with a fully connected cloud platform. FlytEDGE’s game-changing features and intuitive functionality sets it light-years ahead of the competition. Bringing Thales’ FlytEDGE technology to the airline industry means an in-flight experience that is as eagerly awaited as the destination itself, and there’s so much more to look forward to. It is time to embrace the EDGE.
“At Thales we’re always at the forefront of innovation, investing in digital technologies, and working with our partners to redefine the inflight experience. We’re delighted to bring FlytEDGE’s state-of-the-art capabilities to our airline customers to create memorable and fully-tailored passenger interactions.” said Yannick Assouad, Executive Vice-President Avionics, Thales. “FlytEDGE is the first connected cloud-based IFE to introduce ground-breaking new experiences with a true engagement platform offering boundless opportunities for unique journeys. Stay tuned for more exciting news as the system is set to premier on a leading global airline.”
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies within three domains: Defence & Security, Aeronautics & Space, and Cybersecurity and Digital Identity. It develops products and solutions that help make the world safer, greener and more inclusive.
The Group invests close to €4 billion a year in Research & Development, particularly in key innovation areas such as AI, cybersecurity, quantum technologies, cloud technologies and 6G.
Thales has 81,000* employees in 68 countries. In 2023, the Group generated sales of €18.4 billion.
* These figures exclude the ground transportation business, which is being divested
PLEASE VISIT
Thales Group
Thales InFlyt Experience
X @Thalesgroup
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240528532879/en/
Contact information
PRESS CONTACTS
Thales, Media Relations
Head of Media Relations, Aeronautics & Defense
Alice Pruvot
+33 (0)7 70 2711 37
alice.pruvot@thalesgroup.com
Thales, Media Relations
Civil Aeronautics
Chrystelle Dugimont
+33 (0)6 25 15 72 93
chrystelle.dugimont@thalesgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom